ELTP's free cash flow for Q3 2024 was $-2.80M. For the 2024 fiscal year, ELTP's free cash flow was decreased by $-8.41M and operating cash flow was $-2.40M. See a summary of the company’s cash flow.

Cash Flow	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Operating Cash Flow	$ -2.37M	$ 3.34M	$ 6.51M	$ 3.19M	$ -1.79M	$ -6.79M
Investing Cash Flow	$ -942.22K	$ -5.74M	$ -498.57K	$ -262.78K	$ -34.95K	$ 330.87K
Financing Cash Flow	$ -8.75M	$ 1.70M	$ -667.13K	$ -869.83K	$ 689.54K	$ 1.57M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 32.67M	$ 8.24M	$ 8.94M	$ 3.60M	$ 1.54M	$ 2.68M
Income Tax Paid Supplemental Data	$ 588.51K	$ 424.03K	-	-	-	$ 0.00
Interest Paid Supplemental Data	$ 435.73K	$ 1.10M	$ 177.64K	$ 176.18K	$ 240.78K	$ 226.46K
Issuance Of Capital Stock	-	-	-	$ 42.22K	$ 1.44M	$ 2.06M
Issuance Of Debt	$ -8.76M	$ 1.70M	$ -667.13K	$ -291.52K	$ 0.00	-
Repayment Of Debt	$ -12.65M	$ -12.74M	$ -667.13K	$ -105.00K	$ -748.44K	$ -496.68K
Free Cash Flow	$ -3.32M	$ -2.40M	$ 6.01M	$ 2.93M	$ -1.83M	$ -6.81M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Elite Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing